ID

17653

Description

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent

Lien

https://clinicaltrials.gov/ct2/show/NCT00373425

Mots-clés

Versions (2)
  1. 02/08/2016 02/08/2016 -
  2. 27/09/2016 27/09/2016 -
Téléchargé le

27 septembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Anglais

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulaires  
Withdrawal of Treatment Consent
Description

Withdrawal of Treatment Consent

Withdrawal of Treatment Consent: Not Applicable
Description

Withdrawal of Treatment Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0087111
Patient withdrew treatment consent during the study. Date:
Description

Date Consent Withdrawn

Type de données

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Tissue Consent
Description

Withdrawal of Tissue Consent

Withdrawal of Tissue Consent: Not Applicable
Description

Withdrawal of Tissue Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0475358
Patient withdrew tumor tissue consent during the study. Date:
Description

Date Consent Withdrawn

Type de données

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Optional Research Blood Sample Consent
Description

Withdrawal of Optional Research Blood Sample Consent

Withdrawal of Optional Research Blood Sample Consent: Not Applicable
Description

Withdrawal of Optional Research Blood Sample Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0178913
Patient withdrew optional blood sample consent during the study. Date:
Description

Date Consent Withdrawn

Type de données

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Investigator Signature
Description

Investigator Signature

Investigator's Signature
Description

Investigator Signature

Type de données

text

Alias
UMLS CUI [1]
C2346576
Signature Date
Description

Signature date

Type de données

date

Alias
UMLS CUI [1]
C0807937
Retour au début de la page

Similar models

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Withdrawal of Treatment Consent
Withdrawal of Treatment Consent
Item
Withdrawal of Treatment Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew treatment consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Tissue Consent
Withdrawal of Tissue Consent
Item
Withdrawal of Tissue Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew tumor tissue consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Optional Research Blood Sample Consent
Withdrawal of Optional Research Blood Sample Consent
Item
Withdrawal of Optional Research Blood Sample Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew optional blood sample consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigator Signature
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Signature date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial